Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 22;7(1):26.
doi: 10.1186/1939-4551-7-26. eCollection 2014.

Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens

Affiliations
Review

Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens

April Frazier et al. World Allergy Organ J. .

Abstract

We recently identified T cell epitopes associated with human allergic responses. In a majority of cases, responses focused on a few immunodominant epitopes which can be predicted on the basis of MHC binding characteristics. Several observations from our studies challenged the assumption that T cell epitopes are derived from the same allergen proteins that bind IgE. Transcriptomic and proteomics analysis identified pollen proteins, not bound by IgE. These novel Timothy Grass proteins elicited vigorous Th2 responses, suggesting that unlinked T cell help is operational in pollen-specific responses. Thus, the repertoire of antigens recognized by T cells is much broader than IgE-binding allergens. Additionally, we evaluated the use of epitopes from these novel antigens to assess immunological changes associated with Specific Immunotherapy (SIT). We found that a marked decrease in IL5 production is associated with clinically efficacious SIT, suggesting that these novel antigens are potential immunomarkers for SIT efficacy.

Keywords: Cytokine; Epitopes; Specific immunotherapy; T cells; Timothy grass.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scheme of epitope identification process. Diagrammatic representation of the process of antigen, epitope, and biomarker identification as detailed in this review.

References

    1. Cavkaytar O, Akdis CA, Akdis M. Modulation of immune responses by immunotherapy in allergic diseases. Curr Opin Pharmacol. 2014;17C:30–37. doi: 10.1016/j.coph.2014.07.003. - DOI - PubMed
    1. Jutel M, Van de Veen W, Agache I, Azkur KA, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol Int. 2013;62(4):425–433. doi: 10.2332/allergolint.13-RAI-0608. - DOI - PubMed
    1. Petalas K, Durham SR. Allergen immunotherapy for allergic rhinitis. Rhinology. 2013;51(2):99–110. - PubMed
    1. Smarr CB, Bryce PJ, Miller SD. Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol. 2013;33(5):389–414. doi: 10.1615/CritRevImmunol.2013007046. - DOI - PMC - PubMed
    1. Larche M. T cell epitope-based allergy vaccines. Curr Top Microbiol Immunol. 2011;352:107–119. - PubMed